IRIDEX/$IRIX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About IRIDEX
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Ticker
$IRIX
Sector
Primary listing
Employees
93
Headquarters
Website
IRIDEX Metrics
BasicAdvanced
$20m
-
-$0.19
0.65
-
Price and volume
Market cap
$20m
Beta
0.65
52-week high
$1.65
52-week low
$0.87
Average daily volume
63k
Financial strength
Current ratio
1.916
Quick ratio
1.014
Long term debt to equity
81.403
Total debt to equity
90.363
Profitability
EBITDA (TTM)
-2.474
Gross margin (TTM)
35.97%
Net profit margin (TTM)
-6.23%
Operating margin (TTM)
-5.12%
Effective tax rate (TTM)
-3.25%
Revenue per employee (TTM)
$570,000
Management effectiveness
Return on assets (TTM)
-5.38%
Return on equity (TTM)
-56.54%
Valuation
Price to revenue (TTM)
0.38
Price to book
-16.05
Price to tangible book (TTM)
-6.49
Price to free cash flow (TTM)
-7.886
Free cash flow yield (TTM)
-12.68%
Free cash flow per share (TTM)
-0.148
Growth
Revenue change (TTM)
7.73%
Earnings per share change (TTM)
-55.51%
3-year revenue growth (CAGR)
-2.82%
10-year revenue growth (CAGR)
2.06%
3-year earnings per share growth (CAGR)
-24.96%
10-year earnings per share growth (CAGR)
19.28%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs